Implementation and Suggestions for Centralized Drug Procurement in Public Hospitals &#x02014;&#x02014;Taking a Level III A Hospital in Hubei Province as an Example

doi:10.19546/j.issn.1674-3830.2022.4.006

China Health Insurance ›› 2022, Vol. 0 ›› Issue (4) : 33-36. DOI: 10.19546/j.issn.1674-3830.2022.4.006

Implementation and Suggestions for Centralized Drug Procurement in Public Hospitals ——Taking a Level III A Hospital in Hubei Province as an Example

Author information +

History +

Abstract

With the completion of the first batch of centralized volume-based drug procurement (CVDP) in Hubei Province, relevant assessments have been completed. Based on the cases of a Level III A hospital, this article analyzes the impact of CVDP on relevant stakeholders to give suggestions to public hospitals on the better implementation of volume-based drug procurement policies.

Key words

volume-based procurement / selected drugs / related stakeholders

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Implementation and Suggestions for Centralized Drug Procurement in Public Hospitals ——Taking a Level III A Hospital in Hubei Province as an Example[J]. China Health Insurance. 2022, 0(4): 33-36 https://doi.org/10.19546/j.issn.1674-3830.2022.4.006

References

[1] 黎东生,白雪珊.带量采购降低药品价格的一般机理及“4+7招采模式”分析[J].卫生经济研究,2019,36(8):10-12.
[2] 周菁菁,谈在祥.我国药品带量采购政策实施效果研究-以S医院为例.[J].卫生经济研究,2021,38(10):52-55.
[3] 谈在祥,宋青青.药品4+7带量采购扩容背景下公立医院药品供给的法律风险与对策研究.[J].中国卫生事业管理,2020,37(12):913-915,931.
[4] 舒茜,姚峥嵘,王艳翚,等.药品带量采购政策的利益相关者分析.[J].卫生经济研究,2019,36(8):8-9,12.
[5] 杜雪,马珺,黎雯霞.药品带量采购存在的问题与对策分析.[J].卫生经济研究,2020,37(8):42-44,9.
[6] 陈景,李斯妮,李健和,彭六保,彭词艳.国家药品集中带量采购的内在作用机制[J].中国药物经济学,2021,16(12):22-25+29.
[7] 赵洁,李巍,王皋俊.价值医疗视角下国家药品集中带量采购在某公立医院的实施效果评价[J].中国药房,2021,32(19):2410-2414.
[8] 贡雪芃,刘东,魏盈盈,杨红斌,陈顺达,贺国芳.公立医院药品集中带量采购中存在的问题及对策[J].中华医院管理杂志,2021,37(10):827-830.
[9] 董茜,刘秀坤,尹楠楠,谈在祥.“4+7”药品集中带量采购扩围对城市公立医院的影响及其应对[J].中国医院管理,2021,41(08):66-68.